Hunazine Biotech S.L.
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Assessment of a Novel Fixed-dose Combination (FDC) Drug VR-AD-1005 for the Treatment of Acute Watery Diarrhea in Cholera (NCT06193408) | Hunazine Biotech S.L. | 2024-02-11 |
Track Hunazine Biotech S.L. automatically
Every clearance here is in the API, with alerts when new ones post.